Construction,expression,and Identification of Ovarian Anti-Idiotypic Single Chain Antibody 6b11scfv and Mouse HSP70 Fusion Protein

张果,昌晓红,石菁菁,成夜霞,李巍,叶雪,程洪艳,付天云,魏丽惠,崔恒

DOI: https://doi.org/10.3969/j.issn.1673-713x.2008.05.003

2008-01-01

Abstract:Objective To construct the fusion protein of ovarian anti-idiotypic single chain antibody 6B11ScFv and mouse HSP70(6B11ScFv/mHSP70) ,and to detect its immunoactivity. Methods The recombinant plasmid pET30a(+) -6B11ScFv/mHSP70 was constructed by subcloning murine full-length mHSP70 cDNA into the PET30a(+) -6B11ScFv plasmid,using PCR to introduce SpeI/EcoRI restriction site at each terminal of mHSP70 gene. Then the recombinant plasmid was transformed into E.coli DH5α,and the positive clones were screened and confirmed by restriction digestion and DNA sequencing. The correct plasmid was then transformed into E.coli BL21(DE3) to obtain a reconstructed strain,E.coli BL21(DE3) [pET30a(+) -6B11ScFv/mHSP70]. After being induced by IPTG,the expression of the recombinant was analyzed by SDS-PAGE. Afterwards,we isolated,washed,and solubilized the inclusion body,and then performed dilution refolding and affinity chromatography to obtain soluble and pure target protein. The immunoactivity of this fusion protein was detected and determined by Western blotting and ELISA. Results The sequence of fusion gene 6B11ScFv/mHSP70 was identified. SDS-PAGE showed a relative molecular weight of the recombinant protein similar to the expected. The refolding rate of the protein was 20.9% and its purity reached above 95%. As shown by Western blot,the relative molecular weight of the 6B11ScFv/mHSP70 was 104 000,and ELISA revealed that the recombinant strain had both the immunoactivities of 6B11ScFv and mHSP70. Conclusions The recombinant fusion protein 6B11ScFv/mHSP70 has good immunoactivity. Further researches on its in vivo and in intro activity against ovarian cancer is necessary.